CORRESPONDENCE
Coronary angiography is the gold stan dard for assessing coronary artery disease (CAD) and vessel stenosis, but accumulat ing evidence has underscored that, at best, a weak correlation exists between the degree of stenosis and plaque rupture. Vulnerable plaque has, therefore, gained worldwide attention as a major determinant of the risk of developing symptomatic CAD. 1 Given that coronary plaque inflammation has a pivotal role in the development of symp tomatic CAD, 2 functional imaging of this phenomenon might complement infor mation on the anatomical extent of CAD. We read with great interest the Review by Tarkin et al. (PET imaging of inflamma tion in atherosclerosis. Nat. Rev. Cardiol. 11, 443-457; 2014), 3 in which the authors describe noninvasive techniques, such as PET-CT with various tracers, to identify atherosclerotic plaques and stratify the risk of rupture. Such approaches are highly desirable for both disease prevention and to monitor treatment. These observations are commonly limited to large peripheral vessels, but conceptually, these techniques could be applied to the imaging of coronary arteries by capitalizing on the high spatial resolution and sensitivity of PET scanners.
The high spatial resolution afforded by PET has stimulated a variety of approaches to detect vessel inflammation using exist ing or novel radiotracers. Initial clini cal evaluation using 18 Ffluoroxyglucose (FDG) showed promise. 4 However, many subsequent studies have been focused on tracers with more specific targets, such as 18 Ffluoride PET-CT, 5 which can be used to track the presence of active calcification, correlated to macrophage infiltration, apop tosis, and necrosis, as seen in lesions at high risk of rupture. Additionally, the potential of somatostatinreceptorbinding βemitters, such as 68 GaDOTATATE, to identify active macrophage content in atherosclerotic plaques has been investigated. 6 Unfortunately, despite the robust predic tive value reported in patients with CAD, 7 In vivo evaluation of atherosclerotic plaques and culprit lesions using noninvasive techniques Federico Caobelli and Frank M. Bengel widespread uptake of PET imaging is hin dered by high costs, low availability of PET scanners, and the short halflife of some PET tracers, requiring an onsite cyclo tron and radiochemistry specialists, which limits its clinical application to specialized centres. By contrast, singlephoton emission computed tomography (SPECT) cameras are more commonplace, which, coupled with the routine use of radioactive isotopes with a longer halflife than those used for PET, translates to enhanced availability. However, conventional SPECT hardware has limited spatial resolution, which impairs the d elineation of vascular structures.
To overcome these limitations, new SPECT hardware has been introduced, optimized for cardiovascular imaging and equipped with cadmium-zinc-tellurid e (CZT) solidstate scintillators, which pro vide multiple advantages, such as high sensitivity, improved temporal and spatial resolution, and high energy resolution, enabling simul taneous detection of multiple radioisotopes within the energy spectrum. In particular, the higher spatial resolution (6.7 mm versus 15.3 mm for central spatial resolution) and the improved sensitivity with CZT scintil lators facilitate delineation of smaller dif ferences in tracer uptake, allowing finer definition of vascular walls. Tclabelling of autologous leukocytes allowed the infiltration of inflammatory cells to be visualized in atherosclerotic lesions. 8 In this study, scintigraphy with radiolabelled leukocytes was used to detect inflamed vas cular lesions, which correlated well with disease severity. 9 In another study, the feasi bility of using 99m Tchydrazinonicotinamide (HYNIC)interleukin2 SPECT to track lympho cytic infiltration into carotid atherosclerotic lesions was examined. 10 Capitalizing on the improved spatial resolution and sensitivity of CZT cameras might allow this technology to be applied to coronary plaque imaging, as is currently obtainable using PET-CT. Additional bene fits arising from CZT cameras might include improved energy resolution, which would allow simultaneous evaluation of labelled lymphocytic infiltration together with tracers targeting other physio logical processes, including apoptosis ( 111 InDTPAannexin) 11 or angiogenesis ( 111 InRGD peptide). 12 Moreover, the superior performance of CZT cameras might enable absolute quantification of plaque inflammation. CZT technology could also allow a reduction in the radio pharmaceutical dose that is administered, which would lower the radiation exposure to patients. Studies involving larger cohorts of patients imaged with CZT SPECT than have been performed to date are warranted to assess whether vulnerable plaques can be identified with similar accuracy to that achieved using PET imaging. If the results of these trials are robust, the effect on clinical practice will be dramatic, facilitating the widespread func tional evaluation of atherosclerotic plaques. Indeed, the deployment of new SPECT cameras might increase the applicability of this technique, to improve diagnostic accu racy and become a valuable tool in predicting prognosis and therapeutic outcome. Further studies are necessary to define the radiotracer binding thresholds that translate to physio logically relevant plaque inflammation, which would provide a valuable tool in risk stratification of patients. The widespread use of molecular imaging techniques will shift the clinical paradigm away from re sultant anatomy towards causative physiology.
